Alaunos Therapeutics

TCRT · NASDAQ

$2.97−$0.16 (−5.11%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $3.13

Latest news

NewsOct 16, 1:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsOct 16, 4:46 AM ETAvi Kapoor
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
NewsOct 13, 1:20 PM ETVandana Singh
Why is Alaunos Therapeutics Stock Trading 200% Higher on Tuesday?
Press releaseOct 13, 10:31 AM ETGlobe Newswire
Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics
Press releaseOct 13, 7:00 AM ETPRNewswire
Paragon Labs Expands Leadership Team with Former Apogee Executives; Velaris Therapeutics Acquired by Alaunos Therapeutics, Inc.
NewsSep 18, 7:24 AM ET
Market-Moving News for September 18th
NewsSep 18, 4:25 AM ETAvi Kapoor
Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
NewsSep 18, 2:30 AM ETMohd Haider
Alaunos Therapeutics (TCRT) Stock Soars Over 29% After-Hours: Here's What's Going On
Press releaseJun 29, 8:35 AM ETGlobe Newswire
Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study
Press releaseMay 26, 11:01 AM ETGlobe Newswire
Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies
Press releaseMay 18, 8:00 AM ETGlobe Newswire
Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models
Press releaseMay 4, 4:05 PM ETPRNewswire
Valion Bio Appoints Melinda Lackey as General Counsel
NewsApr 21, 5:05 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseMar 2, 6:30 AM ETGlobe Newswire
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders
NewsNov 17, 7:06 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsOct 10, 5:06 AM ETAvi Kapoor
Why Applied Digital Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
NewsOct 9, 5:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsOct 9, 5:12 AM ETAvi Kapoor
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
NewsSep 3, 6:21 AM ETVishaal Sanjay
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week
Press releaseJun 23, 8:00 AM ETGlobe Newswire
Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering
NewsApr 3, 1:06 PM ET
11 Health Care Stocks Moving In Thursday's Intraday Session
NewsApr 1, 1:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsJul 18, 1:19 PM ETAvi Kapoor
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

12 Health Care Stocks Moving In Friday's Intraday Session

Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Why is Alaunos Therapeutics Stock Trading 200% Higher on Tuesday?

Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics

Paragon Labs Expands Leadership Team with Former Apogee Executives; Velaris Therapeutics Acquired by Alaunos Therapeutics, Inc.

Market-Moving News for September 18th

Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Alaunos Therapeutics (TCRT) Stock Soars Over 29% After-Hours: Here's What's Going On

Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study

Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies

Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models

Valion Bio Appoints Melinda Lackey as General Counsel

12 Health Care Stocks Moving In Tuesday's After-Market Session

Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders

12 Health Care Stocks Moving In Monday's Pre-Market Session

Why Applied Digital Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Thursday's After-Market Session

Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week

Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering

11 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session